Aditya Birla Sun Life Pharma and Healthcare Fund vs Bandhan BSE Healthcare Index Fund
Direct Plan, Growth option · Data as on 30-10-2026
Aditya Birla Sun Life Pharma and Healthcare Fund is a Thematic fund and Bandhan BSE Healthcare Index Fund is an Index fund. In the year to 30-10-2026, Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) returned 14.2% and Bandhan BSE Healthcare Index Fund (Direct) returned 12.0%. Aditya Birla Sun Life Pharma and Healthcare Fund charges 1.08% a year and Bandhan BSE Healthcare Index Fund 0.34% (Direct plans). Their portfolios overlap 54.6%: they hold 36 of the same securities.
Aditya Birla Sun Life Pharma and Healthcare Fund
Thematic
- 1 year return
- 14.2%
- Expense ratio
- 1.08%
- NAV
- ₹39.28
Bandhan BSE Healthcare Index Fund
Index
- 1 year return
- 12.0%
- Expense ratio
- 0.34%
- NAV
- ₹11.58
Which is better, Aditya Birla Sun Life Pharma and Healthcare or Bandhan BSE Healthcare Index? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Aditya Birla Sun Life Pharma and Healthcare returned more over 1 year: 14.2% against 12.0%.
- Bandhan BSE Healthcare Index costs less: 0.34% a year against 1.08% (Direct plans).
- Aditya Birla Sun Life Pharma and Healthcare fell less in its worst fall since 09-09-2024: −15.9% against −16.2%.
- Aditya Birla Sun Life Pharma and Healthcare is the larger fund: ₹1,078 Cr against ₹21 Cr.
- Their portfolios overlap 54.6%: 36 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Aditya Birla Sun Life Pharma and Healthcare Fund | Bandhan BSE Healthcare Index Fund |
|---|---|---|
| Fund house | Aditya Birla Sun Life Mutual Fund | Bandhan Mutual Fund |
| Category | Thematic | Index |
| AUM | ₹1,078 Cr (30-09-2026) | ₹21 Cr (31-08-2026) |
| NAV | ₹39.28 (Direct) | ₹11.58 (Direct) |
| Expense ratio (Direct) | 1.08% | 0.34% |
| Expense ratio (Regular) | 2.31% | 1.15% |
| Riskometer | Very High | Very High |
| Benchmark | BSE Healthcare TRI | BSE Healthcare TRI |
| Launch date | 11-07-2019 | 06-09-2024 |
| Minimum investment | ₹1,000 | ₹1,000 |
| Lock in | None | None |
| Fund managers | Dhaval Shah | Abhishek Jain |
| Exit load | Exit load of 1% if redeemed within 30 days. | • 0.25% if redeemed on or before 15 days from the allotment date. • Nil if redeemed after 15 days from allotment date. |
Aditya Birla Sun Life Pharma and Healthcare vs Bandhan BSE Healthcare Index: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) | −1.11% | −2.63% | +12.00% | +14.15% | +21.08% | +14.76% | -- |
| Bandhan BSE Healthcare Index Fund (Direct) | +0.22% | −1.08% | +12.61% | +11.96% | -- | -- | -- |
| Thematic average | −2.09% | −4.52% | +0.86% | −1.22% | +13.76% | +11.62% | -- |
Category average: the average of the 235 Thematic funds, same plan type.
Aditya Birla Sun Life Pharma and Healthcare vs Bandhan BSE Healthcare Index: Year-wise Returns
| Year | Aditya Birla Sun Life Pharma and HealthcareAditya Birla Sun Life Pharma and Healthcare | Bandhan BSE Healthcare IndexBandhan BSE Healthcare Index | BSE Healthcare TRI |
|---|---|---|---|
| 2026to date | +15.94% | +14.73% | +15.08% |
| 2025 | −3.09% | −2.98% | −2.72% |
| 2024 | +37.69% | -- | +44.30% |
| 2023 | +39.58% | -- | +37.97% |
| 2022 | −11.31% | -- | −11.50% |
| 2021 | +21.36% | -- | +21.54% |
Aditya Birla Sun Life Pharma and Healthcare vs Bandhan BSE Healthcare Index: Rolling Returns
Every holding period of both funds, against BSE Healthcare TRI, the benchmark of both
Rolling returns
Every 1-year holding period, 281 of them, one for each trading day from 09-09-2025 to 30-10-2026: the yearly return (CAGR) of each, plotted on the day it ended. One lucky or unlucky start day cannot flatter or hide a fund.
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)
Bandhan BSE Healthcare Index Fund (Direct)
BSE Healthcare TRI
to
Oct 2025Dec 2024
to
Dec 2025Mar 2025
to
Mar 2026May 2025
to
May 2026Jul 2025
to
Jul 2026Sept 2025
to
Sept 2026
How the periods spread
| Fund | Below 0% | 0-5% | 5-10% | 10-15% | 15-20% | 20-25% | Above 25% | Mean | Median | Lowest | Highest | Beat benchmark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare | 17.4 | 20.3 | 13.5 | 23.1 | 21.7 | 3.9 | 0.0 | 8.5% | 9.3% | −5.4% | 21.8% | 77% |
| Bandhan BSE Healthcare Index | 15.5 | 26.8 | 20.1 | 28.2 | 9.5 | 0.0 | 0.0 | 6.9% | 7.2% | −4.0% | 19.1% | 0% |
| BSE Healthcare TRI | 14.2 | 26.0 | 19.9 | 28.5 | 11.4 | 0.0 | 0.0 | 7.3% | 7.5% | −3.7% | 19.5% | -- |
The table shows the % of periods in each return band; a darker cell holds more of them. Lumpsum: the yearly rate (CAGR) from a period's first NAV to its last. SIP: the XIRR of the monthly instalments. The benchmark is BSE Healthcare TRI, over the same periods. "Beat benchmark" counts the periods in which the fund did better. Every fund is measured over the days all of them have, from 09-09-2024. Past returns do not promise future returns.
Aditya Birla Sun Life Pharma and Healthcare vs Bandhan BSE Healthcare Index: SIP and Lumpsum Returns
What the same monthly or one-time investment would be worth in each fund today, from their own NAV history
Growth of an investment
₹10,000 on the first trading day of every month, from 02-09-2024 to 30-10-2026: 26 instalments, ₹2,60,000 in all.
| Investment | Invested | Value now | Gain | Return a year |
|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and HealthcareAditya Birla Sun Life Pharma and Healthcare Fund (Direct) | ₹2,60,000 | ₹2,95,959 | ₹35,959 | 12.0% |
| Bandhan BSE Healthcare IndexBandhan BSE Healthcare Index Fund (Direct) | ₹2,60,000 | ₹2,95,489 | ₹35,489 | 11.9% |
Aditya Birla Sun Life Pharma and HealthcareAditya Birla Sun Life Pharma and Healthcare Fund (Direct)
Bandhan BSE Healthcare IndexBandhan BSE Healthcare Index Fund (Direct)
Amount invested
From each plan's published NAV (Growth option), over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.
Aditya Birla Sun Life Pharma and Healthcare vs Bandhan BSE Healthcare Index: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) | Bandhan BSE Healthcare Index Fund (Direct) |
|---|---|---|
| Return (CAGR) | +14.15% | +11.96% |
| Standard deviation | 12.28% | 13.61% |
| Sharpe ratio | 0.73 | 0.49 |
| Sortino ratio | 1.07 | 0.72 |
| Maximum drawdown | −9.6% (23-10-2026) | −10.0% (23-10-2026) |
| Beta | 0.87 | 1.00 |
| Alpha | +2.70% | −0.41% |
From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) | Bandhan BSE Healthcare Index Fund (Direct) |
|---|---|---|
| Return (CAGR) | +20.52% | +7.26% |
| Standard deviation | 14.89% | 14.58% |
| Sharpe ratio | 1.03 | 0.11 |
| Sortino ratio | 1.51 | 0.15 |
| Maximum drawdown | −20.5% (17-06-2022) | −16.2% (28-02-2025) |
| Beta | 0.88 | 1.00 |
| Alpha | +1.23% | −0.33% |
From daily NAVs, 11-07-2019 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)
Bandhan BSE Healthcare Index Fund (Direct)
BSE Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) | −15.9% | 09-10-2024 | 28-02-2025 | 05-05-2026 | 14 months | −4.7% |
| Bandhan BSE Healthcare Index Fund (Direct) | −16.2% | 02-01-2025 | 28-02-2025 | 29-07-2025 | 5 months | −3.8% |
| BSE Healthcare TRI | −16.2% | 02-01-2025 | 28-02-2025 | 29-07-2025 | 5 months | −3.8% |
From daily values since 09-09-2024, the first day every fund has.
Rolling standard deviation
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 1-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)
Bandhan BSE Healthcare Index Fund (Direct)
BSE Healthcare TRI
Against BSE Healthcare TRI
| Fund | Up capture | Down capture | Tracking error |
|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) | 90% | 93% | 3.99% |
| Bandhan BSE Healthcare Index Fund (Direct) | 99% | 101% | 0.04% |
From month-end values since 09-09-2024. Up capture: a fund's average month when the benchmark rose, as % of the benchmark's; above 100% it gained more. Down capture: the same for months the benchmark fell; below 100% it fell less. Tracking error: how far the monthly returns strayed from the benchmark's, a year; an index fund aims near 0.
Aditya Birla Sun Life Pharma and Healthcare vs Bandhan BSE Healthcare Index: Portfolio Overlap
From each fund's latest monthly portfolio: Aditya Birla Sun Life Pharma and Healthcare Fund, September 2026; Bandhan BSE Healthcare Index Fund, August 2026
Holdings in common
- Overlap
- 54.6%
- Held by both
- 36
- Only in Aditya Birla Sun Life Pharma and Healthcare
- 3
- Only in Bandhan BSE Healthcare Index
- 89
| Security | % of Aditya Birla Sun Life Pharma and Healthcare | % of Bandhan BSE Healthcare Index |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 8.61% | 12.95% |
| Apollo Hospitals Enterprise Ltd. | 6.44% | 5.55% |
| Cipla Ltd. | 6.38% | 4.91% |
| Torrent Pharmaceuticals Ltd. | 9.28% | 4.36% |
| Lupin Ltd. | 2.94% | 3.24% |
| Aurobindo Pharma Ltd. | 4.52% | 2.89% |
| Fortis Healthcare Ltd. | 2.42% | 2.90% |
| Divi's Laboratories Ltd. | 2.24% | 7.22% |
| IPCA Laboratories Ltd. | 2.71% | 1.69% |
| Alkem Laboratories Ltd. | 1.68% | 1.92% |
| Mankind Pharma Ltd. | 3.62% | 1.64% |
| Biocon Ltd. | 1.45% | 1.77% |
| Gland Pharma Ltd. | 2.70% | 1.40% |
| Sai Life Sciences Ltd. | 4.49% | 1.21% |
| Dr. Reddy's Laboratories Ltd. | 1.13% | 4.35% |
| Ajanta Pharma Ltd. | 4.35% | 0.94% |
| Dr. Lal Path labs Ltd. | 3.51% | 0.92% |
| Piramal Pharma Ltd. | 1.22% | 0.82% |
| Abbott India Ltd. | 3.26% | 0.81% |
| Anthem Biosciences Ltd. | 1.13% | 0.77% |
| Glaxosmithkline Pharmaceuticals Ltd. | 0.83% | 0.76% |
| Shilpa Medicare Ltd. | 1.43% | 0.68% |
| Max Healthcare Institute Ltd. | 0.60% | 4.62% |
| Natco Pharma Ltd. | 0.92% | 0.47% |
| Syngene International Ltd. | 0.64% | 0.47% |
| Vijaya Diagnostic Centre Ltd. | 1.04% | 0.45% |
| Pfizer Ltd. | 1.01% | 0.43% |
| Jubilant Pharmova Ltd. | 0.60% | 0.43% |
| Emcure Pharmaceuticals Ltd. | 3.21% | 0.39% |
| Metropolis Healthcare Ltd. | 1.48% | 0.38% |
| Jupiter Life Line Hospitals Ltd. | 1.55% | 0.34% |
| Procter & Gamble Health Ltd. | 1.82% | 0.28% |
| Thyrocare Technologies Ltd. | 1.76% | 0.23% |
| Sanofi Consumer Healthcare India Ltd. | 1.11% | 0.17% |
| Corona Remedies Ltd. | 2.27% | 0.08% |
| Suraksha Diagnostic Ltd. | 1.10% | 0.04% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 54.6% means 54.6% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Aditya Birla Sun Life Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Manipal Health Enterprises Ltd | 1.07% |
| Medi Assist Healthcare Services Ltd. | 0.73% |
| Vinati Organics Ltd. | 0.69% |
Largest holdings only in Bandhan BSE Healthcare Index Fund
| Security | % of fund |
|---|---|
| Laurus Labs Limited | 4.48% |
| Glenmark Pharmaceuticals Limited | 2.28% |
| Zydus Lifesciences Limited | 1.79% |
| Aster DM Quality Care Limited | 1.22% |
| Neuland Laboratories Limited | 1.21% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Aditya Birla Sun Life Pharma and Healthcare | Bandhan BSE Healthcare Index |
|---|---|---|
| Equity | 97.9% | 100.1% |
| Debt | 0.0% | 0.0% |
| Cash and others | 2.1% | -0.1% |
Market cap of stocks
| Market cap | Aditya Birla Sun Life Pharma and Healthcare | Bandhan BSE Healthcare Index |
|---|---|---|
| Large Cap | 32.9% | 35.0% |
| Mid Cap | 30.6% | 38.9% |
| Small Cap | 31.7% | 25.9% |
| Not on AMFI's list | 2.6% | 0.3% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Aditya Birla Sun Life Pharma and Healthcare | Bandhan BSE Healthcare Index |
|---|---|---|
| Pharmaceuticals & Biotechnology | 74.9% | 77.1% |
| Healthcare Services | 21.6% | 22.5% |
| Insurance | 0.7% | 0.0% |
| Chemicals & Petrochemicals | 0.7% | 0.0% |
| Healthcare Equipment & Supplies | 0.0% | 0.5% |
The six largest sectors of each fund's stocks, % of the fund.
Aditya Birla Sun Life Pharma and Healthcare vs Bandhan BSE Healthcare Index: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Aditya Birla Sun Life Pharma and Healthcare Fund | Bandhan BSE Healthcare Index Fund |
|---|---|---|
| Total expense ratio (Direct) | 1.08% | 0.34% |
| Base expense ratio (Direct) | 0.84% | 0.19% |
| Total expense ratio (Regular) | 2.31% | 1.15% |
| Base expense ratio (Regular) | 1.91% | 0.88% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare Aditya Birla Sun Life Pharma and Healthcare with
- Aditya Birla Sun Life Pharma and Healthcare vs Nippon India Taiwan Equity
- Aditya Birla Sun Life Pharma and Healthcare vs HDFC Defence
- Aditya Birla Sun Life Pharma and Healthcare vs HDFC Pharma and Healthcare
- Aditya Birla Sun Life Pharma and Healthcare vs SBI Healthcare Opportunities
- Aditya Birla Sun Life Pharma and Healthcare vs Aditya Birla Sun Life International Equity
Aditya Birla Sun Life Pharma and Healthcare Fund vs Bandhan BSE Healthcare Index Fund: Frequently Asked Questions
What is the difference between Aditya Birla Sun Life Pharma and Healthcare Fund and Bandhan BSE Healthcare Index Fund?
Aditya Birla Sun Life Pharma and Healthcare Fund is a Thematic fund, Bandhan BSE Healthcare Index Fund is an Index fund, run by Aditya Birla Sun Life Mutual Fund and Bandhan Mutual Fund. Their portfolios overlap 54.6%. Aditya Birla Sun Life Pharma and Healthcare Fund charges 1.08% a year and Bandhan BSE Healthcare Index Fund 0.34%.
Which has given higher returns, Aditya Birla Sun Life Pharma and Healthcare Fund or Bandhan BSE Healthcare Index Fund?
Over 1 year: Aditya Birla Sun Life Pharma and Healthcare Fund +14.15%, Bandhan BSE Healthcare Index Fund +11.96%. As on 30-10-2026. Past returns do not promise future returns.
Which has the lower expense ratio, Aditya Birla Sun Life Pharma and Healthcare Fund or Bandhan BSE Healthcare Index Fund?
Bandhan BSE Healthcare Index Fund charges less: 0.34% a year against 1.08%. These are the Direct plans' total expense ratios reported to AMFI.
How much do Aditya Birla Sun Life Pharma and Healthcare Fund and Bandhan BSE Healthcare Index Fund overlap?
54.6%. They hold 36 of the same securities, the largest shared ones being SUNPHARMA, APOLLOHOSP, CIPLA. From each fund's latest monthly portfolio.
Which is riskier, Aditya Birla Sun Life Pharma and Healthcare Fund or Bandhan BSE Healthcare Index Fund?
On SEBI's riskometer, Aditya Birla Sun Life Pharma and Healthcare Fund is rated Very High and Bandhan BSE Healthcare Index Fund Very High. Over 1 years, the standard deviation of daily returns was 12.28% and 13.61% a year.
Can I invest in both Aditya Birla Sun Life Pharma and Healthcare Fund and Bandhan BSE Healthcare Index Fund?
Yes. 54.6% of each fund's money sits in the same holdings, so a large part of the two investments would move together.
Who manages Aditya Birla Sun Life Pharma and Healthcare Fund and Bandhan BSE Healthcare Index Fund?
Aditya Birla Sun Life Pharma and Healthcare Fund: Dhaval Shah. Bandhan BSE Healthcare Index Fund: Abhishek Jain.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.